MBNL1 and myotonic dystrophy type 1: These data indicate that nuclear MBNL1 aggregation in the DM1 myotubes is a reversible phenotype and that our in vitro DM1 model enables evaluation of the therapeutic effect of candidate drugs for DM1 on nuclear MBNL1 aggregation.